CIK 0001783328
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
TScan Therapeutics, Inc.
Sign in to watch- Ticker
- TCRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825282075
- Phone
- +1 857-399-9500
- Business address
- 830 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-02 | SOUTHWELL DAVID P Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-07-25 | SOUTHWELL DAVID P Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2022-05-18 | SOUTHWELL DAVID P Chief Executive Officer | Purchase | +15,000 | $3.62 | $54K | 161,569 |
| 2022-05-18 | SOUTHWELL DAVID P Chief Executive Officer | Purchase | +10,000 | $3.55 | $35K | 171,569 |
| 2022-01-18 | SOUTHWELL DAVID P Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +275,000 | 275,000 | ||
| 2021-12-23 | SOUTHWELL DAVID P Chief Executive Officer | Option exercise | +48,670 | $1.97 | $96K | 146,569 |
| 2021-12-23 | SOUTHWELL DAVID P Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −48,670 | 21,161 | ||
| 2021-09-08 | SOUTHWELL DAVID P Chief Executive Officer | Purchase | +11,000 | $8.73 | $96K | 97,899 |
Page 1 of 1 · 8 trades